Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Single-arm Study to Evaluate the Safety and Efficacy of a Novel Transcatheter Pulmonary Thrombectomy System Which Named 'TwiFlow' for Acute Pulmonary Embolism

NCT05792397 is registered in ClinicalTrials.gov with Morningside (Nantong) Medical Co.,Ltd as lead sponsor.

NCT NCT05792397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05792397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Single-arm Study to Evaluate the Safety and Efficacy of a Novel Transcatheter Pulmonary Thrombectomy System Which Named 'TwiFlow' for Acute Pulmonary Embolism
Lead sponsor
Morningside (Nantong) Medical Co.,Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2023
Completion date
May 1, 2026
Enrollment
127 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute pulmonary embolism